======= MORF4L1 =======
== Gene Information ==
* **Official Symbol**: MORF4L1
* **Official Name**: mortality factor 4 like 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10933|10933]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBU8|Q9UBU8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MORF4L1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MORF4L1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607303|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when directly recruited to sites of DNA damage. Also component of the mSin3A complex which acts to repress transcription by deacetylation of nucleosomal histones. Required for homologous recombination repair (HRR) and resistance to mitomycin C (MMC). Involved in the localization of PALB2, BRCA2 and RAD51, but not BRCA1, to DNA-damage foci. {ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:20332121}.
|Tudor-knot|
|MRG|
|Sin3 complex|
|histone H2A acetylation|
|NuA4 histone acetyltransferase complex|
|histone acetyltransferase complex|
|histone deacetylation|
|protein deacetylation|
|histone H4 acetylation|
|chromatin organization involved in negative regulation of transcription|
|chromatin silencing|
|protein deacylation|
|macromolecule deacylation|
|chromatin organization involved in regulation of transcription|
|negative regulation of gene expression, epigenetic|
|double-strand break repair via homologous recombination|
|recombinational repair|
|protein N-terminus binding|
|histone acetylation|
|internal peptidyl-lysine acetylation|
|peptidyl-lysine acetylation|
|internal protein amino acid acetylation|
|protein acetylation|
|gene silencing|
|double-strand break repair|
|protein acylation|
|DNA recombination|
|regulation of gene expression, epigenetic|
|peptidyl-lysine modification|
|histone modification|
|covalent chromatin modification|
|chromatin binding|
|nuclear speck|
|DNA repair|
|cell population proliferation|
|regulation of growth|
|chromatin organization|
|DNA metabolic process|
|cellular response to DNA damage stimulus|
|peptidyl-amino acid modification|
|chromosome organization|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|cellular response to stress|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|-2.51|
|[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-2.14|
|[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-2.12|
|[[:results:exp216|Erlotinib 10μM R05 exp216]]|-2.04|
|[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|-2.04|
|[[:results:exp275|Citral 75μM R06 exp275]]|-1.95|
|[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-1.92|
|[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|-1.86|
|[[:results:exp210|LB-100 2μM R05 exp210]]|-1.82|
|[[:results:exp452|Azithromycin 100μM R08 exp452]]|-1.81|
|[[:results:exp512|Olaparib 4μM R08 exp512]]|-1.77|
|[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-1.71|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7115
* **Expression level (log2 read counts)**: 7.98
{{:chemogenomics:nalm6 dist.png?nolink |}}